Clinical Trials Logo

Filter by:
NCT ID: NCT02304393 Completed - Solid Tumors Clinical Trials

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

Start date: December 12, 2014
Phase: Phase 1
Study type: Interventional

This is an open-label, multicenter study designed to assess the safety, pharmacokinetics, pharmacodynamics and activity of Selicrelumab administered in combination with Atezolizumab (ATZ) in participants with metastatic or locally advanced solid tumors. The study will be conducted in two Parts (I and II), with Part I divided into Parts IA and IB. All participants will be followed up for survival until death or loss of follow-up after the last visit or withdrawal of consent.

NCT ID: NCT02303756 Completed - Rectal Bleeding Clinical Trials

Colonic Capsule Endoscopy (CCE) for Screening of Neoplasm's A Pilot Study

Start date: August 2015
Phase: N/A
Study type: Interventional

The primary aim is to evaluate the efficiency of capsule endoscopy (CCE) in in the detection of neoplasms compared to conventional colonoscopy in persons participating in the Danish screening program for colorectal cancer with a positive fecal occult blood with the colonoscopy being the gold standard.

NCT ID: NCT02303483 Completed - Obese Clinical Trials

The Effect of Vitamin B3 on Substrate Metabolism, Insulin Sensitivity, and Body Composition in Obese Men

Start date: January 4, 2016
Phase: N/A
Study type: Interventional

In animals, treatment with vitamin B3 improved insulin sensitivity and substrate metabolism. It is currently not know if vitamin B3 has the same positive effects in humans. In the current study the effect of a 3 month treatment with vitamin B3 on insulin sensitivity and substrate metabolism in obese men will be investigated.

NCT ID: NCT02303249 Completed - Discharge Planning Clinical Trials

Interventional Study of Videoconferences Between Hospital and Municipality - a Randomized Controlled Trial

Tele-hjem
Start date: July 2013
Phase: N/A
Study type: Interventional

The study aims to assess whether the review of discharge planning followed by a cross-sectoral video conference in connection with discharge of medical and geriatric patients at Roskilde and Køge hospitals as well as patients from the Emergency Department at Køge Hospital reduces the proportion of patients who are readmitted within 180 days. Project nurses at the two hospitals identifies all patients fulfilling the inclusion criteria (above 55 years of age, discharged to their own home), get informed consent and performs the video conferences. Within a few hours after discharge a video conference is held in the patient´s home including the patient,the municipal nurse and the project nurse at the hospital. During the video conference the discharge is reviewed using a structured assessment. The survey is conducted as an open, randomized intervention study.

NCT ID: NCT02303236 Completed - Heart Failure Clinical Trials

Biological Markers Predicting Exercise Capacity in CF-LVAD Patients.

Start date: November 2014
Phase: N/A
Study type: Observational

Establishing the association between biological markers and exercise capacity in continuous-flow left ventricular assist device patients.

NCT ID: NCT02303106 Completed - Healthy Clinical Trials

Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study

Start date: November 2014
Phase: Phase 4
Study type: Interventional

The investigators will study the effect of paracetamol on the steady state metabolism of lamotrigine in 12 healthy male volunteers. Subjects will receive lamotrigine, slowly titrated from 25 mg daily to 100 mg daily over 28 days. On day 36, full plasma and urine PK samples will be drawn. On days 37-40 the subject will be co-administered 1 gr paracetamol 4 times daily. On day 40 the sampling will be repeated. Primary outcome parameter is Lamotrigine AUC before and after coadministration of paracetamol.

NCT ID: NCT02303067 Completed - Clinical trials for Coronary Artery Disease

Prospective International Study of Coronary Subtraction Using 320 Detector Row CT (CorSub)

Start date: January 6, 2015
Phase:
Study type: Observational

Background: - This study is designed for people who need a standard, non-research invasive coronary angiogram to find out if they have heart disease. Researchers want to take a computed tomography (CT) scan of people s hearts before their procedure to see if this less invasive test can also diagnose coronary artery disease. Objectives: - To learn if a new way to view CT pictures is able to accurately diagnose coronary artery disease. Eligibility: - People age 55 and older who need a coronary angiogram. Design: - Participants will be screened with their medical records. - Participants may give a blood sample. - Participants may have a CT scan of the heart with and without contrast. The CT scan will not interfere with their medical care. - Participants blood pressure and heart rhythm will be monitored before, during, and after the CT scan. They may have an electrocardiogram. - Before the scan, participants will have an intravenous catheter put into their arm. It will be used to inject contrast. - Participants may take a beta blocker to slow their heart rate. - Participants may take nitroglycerin under their tongue. It will enlarge their heart blood vessels and improve picture quality. It may cause a flushing sensation or headache. - Participants will lie on their back on a padded table. The table slides into a large, donut-shaped machine. An x-ray tube will move around their body, taking pictures. They will be asked to hold their breath for 5 seconds at a time. - Participants will be called 30 days after their angiogram. They will answer questions about their health, hospital visits, or medical treatments.

NCT ID: NCT02303015 Completed - Germ Cell Cancer Clinical Trials

Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

Start date: August 2014
Phase:
Study type: Observational

The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.

NCT ID: NCT02302807 Completed - Bladder Cancer Clinical Trials

A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]

Start date: January 13, 2015
Phase: Phase 3
Study type: Interventional

This is a Phase III, global, multicenter, open-label, two-arm, randomized, controlled study designed to evaluate the efficacy and safety of atezolizumab compared with chemotherapy in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have progressed during or following a platinum-containing regimen. The anticipated time on study treatment is based on continued clinical benefit, i.e., until disease progression or unacceptable toxicity. The target sample size is 931 participants.

NCT ID: NCT02301624 Completed - Clinical trials for Refractory Generalized Myasthenia Gravis

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Start date: November 12, 2014
Phase: Phase 3
Study type: Interventional

To evaluate the safety and efficacy of eculizumab in the treatment of refractory generalized myasthenia gravis (gMG) as an extension study for the participants who previously completed Study ECU-MG-301(NCT01997229).